Watson Laboratories receives FDA approval for Tacrolimus ANDA
Links shared publicly online about this topic.
- 1,052total visits
Watson Laboratories receives FDA approval for Tacrolimus ANDA
View full resource at news-medical.net
Tags: Organ Transplant Rejection Medication, Drug, Pharma, Health Insurance, Medicare, FDA, Prograf, Watson Pharmaceuticals
Most Recently Shared on July 2, 2010 at 1:36 pm By:
Medicare News: Watson Laboratories receives FDA approval for Tacrolimus ANDA: Watson Pharmaceuticals, Inc., today ... http://bit.ly/by9Qwh
Watson Laboratories receives FDA approval for Amlodipine capsules
news-medical.net — “Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.” View full resource at news-medical.net
Most Recently Shared on October 15, 2010 at 1:16 pm By:
Watson Laboratories receives FDA approval for Amlodipine capsules: Watson Pharmaceuticals, Inc. today announced th... http://bit.ly/aJkNVe
Watson receives US FDA approval for generic equivalent of Bayer's Yasmin - Corporate
pharmabiz.com — “Watson Pharmaceuticals subsidiary, Watson Laboratories, Inc., recently received approval from the US FDA for its ANDA for zarah (drospirenone and ethinyl estradiol tablets) 3 mg/0.03 mg, the generic equivalent to Bayer's Yasmin.” View full resource at pharmabiz.com
Most Recently Shared on September 8, 2010 at 1:10 pm By:
Urology & Nephrology OW Health
Watson receives US FDA approval for generic equivalent of Bayer's Yasmin: Watson Pharmaceuticals subsidiary, Watso... http://bit.ly/biaajj
Advertisement
